|
1.
|
|
Calpain inhibitor causes accumulation of ubiquitinated P-glycoprotein at the cell surface :possible role of calpain in P-glycoprotein turnover. 1999/05
|
|
2.
|
|
Caspase-3 activation during apoptosis caused by doxorubicin-glutathione conjugate. 1999/05
|
|
3.
|
|
Calpain inhibitor inhibits secretory granule maturation and secretion of GH. 2000/06
|
|
4.
|
|
Suppression of GST-P by treatment with glutathione-doxorubicin conjugate induces potent apoptosis in rat hepatoma cells 2001/05
|
|
5.
|
|
Relationship between cytocidal activity and glutathione S-transferase inhibition using doxorubicin coupled to stereoisomers of glutathione which are different substrate specificity. 2001/08
|
|
6.
|
|
Level of glutathione S-transferase-p expression regulates sensitivity to glutathione-doxorubicin conjugate. 2001/09
|
|
7.
|
|
Acetaldehyde-induced growth retardation and micro-heterogeneity of the sugar chain in transferrin synthesized by Hep.G2 cells. 2002/05
|
|
8.
|
|
Establishment and some characteristics of epoximicin (a proteasome inhibitor) resistant variants of the human squamous cell cartinoma cell line, A431. 2004/04
|
|
9.
|
|
Chemotherapeutic agent which induced mitochondrial apoptosis. 2004/10
|
|
10.
|
|
Relationship between expression of drug-resistance factors and drug sensitivity in normal human renal proximal tubular epithelial cells in comparison with renal cell carcinoma. 2005/07
|
|
11.
|
|
Conformational change in the active center region of GST P1-1, due to binding of a synthetic conjugate of DXR with GSH, enhanced JNK-mediated apoptosis. 2007/07
|
|
12.
|
|
Survivin expression in early hepatocellular carcinoma and post-treatment with anti-cancer drug under hypoxic culture condition. 2007/10/28
|
|
13.
|
|
The association of deamidation of Bcl-xL and translocation of Bax to the mitochondria through activation of JNK in the induction of apoptosis by treatment with GSH-conjugated DXR. 2008/08
|
|
14.
|
|
Three-dimentional culture using a radial flow bioreactor induces matrix metalloprotease 7-mediated EMT-like process in tumor cells via TGFb1/Smad pathway. 2009/03
|
|
15.
|
|
Target chemotherapy using GSH-DXR conjugate encapsulated with anti-CD147 antibody-labeled liposome for carcinoma cells with high-level expression of CD147. 2010/01
|
|
16.
|
|
Three dimensional culture promotes reconstitution of the tumor specific hypoxic microenvironment under TGFbeta stimulation. 2011/07
|
|
17.
|
|
Hypoxia promotes glycogen synthesis and accumulation in human ovarian clear cell carcinoma. 2012/03
|
|
18.
|
|
Proteasome inhibitor-resistant cells caused EMT-induction via suppression of E-cadherin by miR-200 and ZEB1. 2015/03
|
|
19.
|
|
Development of the reversal drug for the anticancer drug-resistant cells, and target chemotherapy. 2016/01
|
|
20.
|
|
Antibody to human α-fetoprotein inhibits cell growth of human hepatocellular carcinoma cells by resuscitating the PTEN molecule: in vitro experiments 2017/05
|
|
21.
|
|
Chemotherapeutic Effect of Anti-CD147 Antibody Labelled Micelles Encapsulating a Conjugate of Doxorubicin with Glutathione Targeting CD147-Expressing Carcinoma Cells. 2018/04
|
|
22.
|
|
Clinical implications of drugscreening assay for recurrent metastatic hormone receptorpositive, human epidermal receptor 2-negative breast cancer using conditionally reprogrammed cells. 2019/09/16
|
|
23.
|
|
Measurements of radiocesium in animals, plants and fungi in Svalbard after the Fukushima Daiichi nuclear power plant disaster. 2019/12
|
|
Display 5 items
|
|
Display all(23)
|
